
PostEra
PostEra is a YC Winter 2020 (W20) company. Based in Boston, MA, USA. Team of 40.
About PostEra
Summary
PostEra builds Proton, an AI platform for medicinal chemistry, to discover and develop small molecule drugs. It serves biopharma companies by accelerating the chemistry work that traditionally bottlenecks drug programs, while also advancing its own internal pipeline. PostEra also led COVID Moonshot, an open-science effort to find antiviral drug candidates.
Go-to-market
Biopharma companies and research institutions engage PostEra through multi-year partnership agreements; PostEra also runs an internal drug discovery pipeline and has licensed programs to acquirers such as Merck KGaA.
From the Y Combinator listing
Medicinal Chemistry powered by Machine Learning
PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- Boston, MA, USA
- 40
- Active
- Growth
Founders (3)
- Aaron Morris
- Alpha Lee
- Matthew Robinson
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works